Diabetes mellitus, type 1 Trials in Tallahassee, United States
Conditions / Diabetes mellitus, type 1 / Tallahassee, United States
Diabetes mellitus, type 1 has been the subject of sustained clinical investigation across multiple research sites.
14 total trials for this combination
Showing top 10 of 14 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00773279 | Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics | COMPLETED | PHASE3 |
| NCT00071448 | Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population | COMPLETED | PHASE3 |
| NCT07222332 | A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE) | RECRUITING | — |
| NCT02670915 | Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes | COMPLETED | PHASE3 |
| NCT00137046 | Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 1 Diabetes | TERMINATED | PHASE3 |
| NCT06071325 | Green Digital Diabetes Waste Project | COMPLETED | — |
| NCT00097071 | Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents | COMPLETED | PHASE3 |
| NCT01835431 | A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus | COMPLETED | PHASE3 |
| NCT07222137 | A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults | RECRUITING | — |
| NCT01513473 | A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus | COMPLETED | PHASE3 |